Aurobindo Pharma receives FDA Approval for Raloxifene Hydrochloride.
29 Aug 2015
Auro received the final approval from USFDAfor Raloxifene Hydrochloride Tablets 60mg.
It has estimated market size of US$404 Million for the twelve months ending June 2015 according to IMS.
This is the 45th ANDA to be approved out of Unit VII formulation facility in Hyderabad, India for
manufacturing Oral Non-Antibiotic products.It now has a total of 210 ANDA approvals.
Raloxifen.pdf (76.2 KB)
| Subscribe To Our Free Newsletter |
